AstraZeneca Imfinzi recommended for approval in EU for adults with muscle-invasive bladder cancer Ruchika Sharma29 May 2025 2:15 PM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) for the...
AstraZeneca Pharma India gets CDSCO Panel nod for Anti-cancer Drug Osimertinib Tablets 40 mg and 80 mg Dr. Divya Colin20 May 2025 6:00 PM ISTNew Delhi: With the condition of conducting a Phase IV clinical trial study, the Subject Expert Committee (SEC) functional under the Central Drug...
AstraZeneca successfully completes acquisition of EsoBiotec Ruchika Sharma20 May 2025 12:27 PM ISTAstraZeneca has successfully completed the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated...
AstraZeneca Trixeo Aerosphere approved in UK as inhaled respiratory medicine using next-generation propellant with near-zero Global Warming Potential Ruchika Sharma13 May 2025 10:30 AM ISTCambridge: AstraZeneca's Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF), already licensed for the treatment of...
AstraZeneca Calquence plus chemoimmunotherapy approved in EU for 1st-line mantle cell lymphoma Ruchika Sharma7 May 2025 12:30 PM ISTCambridge: AstraZeneca has announced that Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the...
Medical Bulletin 05/ May/ 2025 Dr. Garima Soni5 May 2025 3:00 PM ISTHere are the top medical news for the day:Too Much Chicken? New Research Finds Link to Increased Risk of Early DeathA recent study published in the...
AI-Enabled X-Rays Help Detect Lung Cancer Risk in 50,000 Patients Worldwide: Study Shows Dr. Garima Soni5 May 2025 8:30 AM ISTAstraZeneca, in partnership with health-tech company Qure.ai, has successfully completed over 5 million artificial intelligence (AI)-enabled chest...
AstraZeneca Breztri met primary endpoints in Phase III trials in asthma Ruchika Sharma4 May 2025 10:30 AM ISTAstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that...
Fixed duration Calquence based regimens recommended for EMA Committee for chronic lymphocytic leukaemia: AstraZenaca Ruchika Sharma30 April 2025 1:30 PM ISTAstraZeneca has announced that a fixed-duration regimen of Calquence (acalabrutinib) in combination with venetoclax, with or without...
AstraZeneca discontinues Phase 3 trial of Truqap in metastatic castration-resistant prostate cancer Ruchika Sharma30 April 2025 12:14 PM ISTTruqap was discovered by AstraZeneca subsequent to a collaboration with Astex Therapeutics.
AstraZeneca rejoins leading US drug lobby group Ruchika Sharma23 April 2025 9:30 AM ISTAstraZeneca has rejoined the Pharmaceutical Research and Manufacturers of America (PhRMA), the main U.S. drug lobby group, nearly two years...
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancer Ruchika Sharma4 April 2025 3:30 PM ISTCambridge: AstraZeneca has announced that the Company's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union...
